[Long-term safety and efficacy of high-dose cytarabine consolidation in patients with acute myeloid leukemia]

Zhonghua Xue Ye Xue Za Zhi. 2017 Apr 14;38(4):330-333. doi: 10.3760/cma.j.issn.0253-2727.2017.04.013.

[Article in Chinese]

Authors

X X Cao, S J Wang, M H Duan, T N Zhu, W Zhang, B Han, J L Zhuang, H C Cai, M Chen, J Feng, X Han, Y Zhang, C Yang, L Zhang, D B Zhou, J Li

PMID: 28468096
PMCID: PMC7342724
DOI: 10.3760/cma.j.issn.0253-2727.2017.04.013

No abstract available

MeSH terms

Antimetabolites, Antineoplastic
Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Humans
Leukemia, Myeloid, Acute*
Remission Induction

Substances

Antimetabolites, Antineoplastic
Cytarabine